Bruising at the Wegovy Injection Site: Causes, Care and When to Act

Bruising at the Wegovy injection site is common and usually resolves on its own within three to seven days.
Rotating injection sites — abdomen, thigh and upper arm — reduces repeated trauma to the same patch of skin.
Injecting too quickly, pressing too hard, or reusing a needle are the most frequent causes of avoidable bruising.
Persistent bruising, a growing lump, or signs of infection warrant prompt clinical review rather than a wait-and-see approach.

A small bruise at the Wegovy injection site is one of the most common things people notice in the first few weeks of treatment. It happens because the needle passes through tiny blood vessels just under the skin, and it usually fades within a few days without any treatment. It is not a sign that something has gone wrong. That said, there are practical steps you can take to reduce bruising, and a few situations where it is worth contacting a clinician. Wegovy is a prescription-only medicine, so any concerns about your technique or your skin's response are worth raising with the prescriber who oversees your care.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A practical, step-by-step guide to bruising from Wegovy injections, causes, technique fixes and red flags

Step 1: Understand what causes a bruise at the injection site

When a fine needle enters the subcutaneous layer of fat beneath the skin, it can clip a tiny capillary. Blood leaks into the surrounding tissue, and the familiar purple or yellow-green mark appears. This is a mechanical event, not a reaction to the medicine itself. It has nothing to do with the dose level, and it does not mean the pen failed to deliver semaglutide.

A few factors make it more likely. Injecting quickly rather than pressing the pen steadily and allowing the full dose to be delivered before removing it is a common culprit. So is pressing the pen too firmly against the skin, a gentle, flat contact is all that is needed. Cold medicine can also increase localised discomfort and minor bleeding; letting the pen reach room temperature for about twenty to thirty minutes before use helps. You can read more about good technique in our guide to Wegovy injection site care.

One misconception worth clearing up: if you want a closer look at why a bruise from a Wegovy injection appears and what it typically looks like, our dedicated page walks through the causes in detail. A tiny bead of blood at the surface means a capillary was nicked, not that the medicine seeped back out. Apply gentle pressure with a clean dry cloth for thirty seconds and carry on.

Step 2: Adjust your technique to reduce future bruising

Most bruising linked to Wegovy injections responds well to small changes in how the injection is given. The upper arm is a valid site and some people find it bruises less than the abdomen, though everyone's skin responds differently.

Rotating properly is the single most effective habit. Inject in a different spot each week, keeping new injections at least a few centimetres from the last one. The NHS guidance on semaglutide notes the abdomen, thigh and upper arm as approved sites; the Mounjaro patient information leaflet gives the same three for tirzepatide. Staying within the same region but shifting position each week allows skin to recover.

Needle condition matters too. Each pen is designed for one needle per injection. Reusing a needle bends its tip microscopically, increasing drag through the skin and the chance of capillary damage. Our 100-pack of compatible needles is an easy way to keep a fresh needle available for every dose.

Finally, do not rub the site after injecting. Rubbing disperses the medicine unevenly and increases bruise size. A light press, then leave it alone.

Step 3: Know when a bruise needs more than patience

The vast majority of bruises linked to Wegovy injections resolve without any intervention. What you are looking out for is anything that falls outside the expected pattern. See your prescriber or GP promptly if the bruise is spreading after forty-eight hours rather than fading, if it feels warm and firm, or if the skin above it is red and tender in a way that suggests infection rather than simple bruising. A hard lump that persists beyond two weeks may indicate lipohypertrophy (fatty tissue changes from repeated injections in the same spot) which is manageable but worth discussing.

Very heavy bruising, particularly if you are also taking blood-thinning medicines, should be flagged with your prescriber before your next injection. If you ever have any doubt about whether a skin reaction is within the normal range, contacting your clinical team is the right call, not something to put off. The NHS medicines information for semaglutide lists injection-site reactions including bruising as a recognised side effect, which is reassuring context when you spot one, and notes the situations that need medical attention.

You can also report any side effect (including unexpected skin reactions) through the MHRA's Yellow Card scheme, which helps regulators monitor real-world safety signals for medicines like Wegovy.

For a broader look at what the injection experience involves day to day, our overview of Wegovy as a weight-loss injection covers what to expect from the full course of treatment.

Step 4: When to involve your prescriber proactively

Bruising is one of those side effects that feels more alarming than it is, but it is still worth mentioning at your next clinical review, not least because persistent bruising at a specific site can signal that technique needs refining, and a prescriber can advise precisely. At nume, every repeat order is reviewed by a real clinician before it is approved, so there is a natural opportunity to raise this kind of question. You are not raising an emergency; you are using the support that is built in.

If you are considering starting Wegovy and want to understand the full picture before your first pen arrives, the Wegovy information page covers mechanism, eligibility and what the evidence says about weight loss outcomes. And if cost context is useful at this stage, our Wegovy price comparison guide explains what a legitimate private prescription includes and why the cheapest listing is rarely the most useful measure for a prescription medicine. When you are ready to take the next step, you can start your free consultation with our prescribing team.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions